Contact Us
Drug Search Results
More Filters [+]

Telatinib

Alternative Names: telatinib
Latest Update: 2024-10-10
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: TK Inhibitor,VEGFR Inhibitor,VEGFR Inhibitor,PGFR Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: ACT Biotech
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Telatinib

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Hepatocellular Carcinoma|Gastrointestinal Cancer

Phase 1: Gastrointestinal Cancer|Vascular Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
IIT2020-11-Hendifar-TELAT

P2

Active, not recruiting

Gastrointestinal Cancer|Hepatocellular Carcinoma

2024-02-14

EOC315B2101

P2

Unknown status

Gastrointestinal Cancer

2020-03-30

53%
EOC315001

P1

Completed

Vascular Cancer|Gastrointestinal Cancer

2018-08-15

34%
TEL0805

P2

Completed

Gastrointestinal Cancer

2011-10-01

Recent News Events

Date

Type

Title

09/28/2021

News Article

 Global Gastric Cancer Pipeline Landscape Report 2021 - Comprehensive Insights About 100+ Companies and 100+ Pipeline Drugs - ResearchAndMarkets.com

05/19/2021

News Article

 LogicBio Therapeutics Promotes Daniel Gruskin, MD, to Chief Medical Officer and Announces Additional Leadership Appointments

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions